Eric Venker Roivant Sciences Ltd. (ROIV) insider trading activity

Eric Venker is President & COO of Roivant Sciences Ltd.. Currently has a direct ownership of 740,976 shares of ROIV, which is worth approximately $7.88 Million. The most recent transaction as insider was on Dec 30, 2024, when has been sold 177,704 shares (Common Shares) at a price of $11.54 per share, resulting in proceeds of $2,050,704. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 741K

17.91% 3M change

36.06% 12M change

Total Value Held $7.88 Million

Eric Venker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 30 2024	SELL Open market or private sale	$2,050,704 $11.54 p/Share	177,704 Reduced 19.34%	740,976 Common Shares
Dec 30 2024	BUY Exercise of conversion of derivative security	$962,500 $3.85 p/Share	250,000 Added 21.39%	918,680 Common Shares
Dec 27 2024	SELL Open market or private sale	$2,090,958 $11.82 p/Share	176,900 Reduced 20.92%	668,680 Common Shares
Dec 27 2024	BUY Exercise of conversion of derivative security	$962,500 $3.85 p/Share	250,000 Added 22.82%	845,580 Common Shares
Dec 20 2024	SELL Payment of exercise price or tax liability	$126,633 $11.57 p/Share	10,945 Reduced 1.8%	595,580 Common Shares
Dec 20 2024	SELL Open market or private sale	$1,149,000 $11.49 p/Share	100,000 Reduced 14.38%	595,580 Common Shares
Dec 20 2024	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 12.57%	695,580 Common Shares
Nov 20 2024	SELL Payment of exercise price or tax liability	$125,758 $11.49 p/Share	10,945 Reduced 1.77%	606,525 Common Shares
Nov 20 2024	SELL Open market or private sale	$1,132,000 $11.32 p/Share	100,000 Reduced 14.15%	606,525 Common Shares
Nov 20 2024	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 12.4%	706,525 Common Shares
Oct 21 2024	SELL Open market or private sale	$1,165,000 $11.65 p/Share	100,000 Reduced 13.94%	617,470 Common Shares
Oct 21 2024	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 12.23%	717,470 Common Shares
Oct 20 2024	SELL Payment of exercise price or tax liability	$130,464 $11.92 p/Share	10,945 Reduced 1.74%	617,470 Common Shares
Sep 20 2024	SELL Payment of exercise price or tax liability	$131,011 $11.97 p/Share	10,945 Reduced 1.71%	628,415 Common Shares
Aug 20 2024	SELL Payment of exercise price or tax liability	$125,671 $11.48 p/Share	10,947 Reduced 1.68%	639,360 Common Shares
Jul 26 2024	BUY Grant, award, or other acquisition	-	204,000 Added 23.88%	650,307 Common Shares
Jul 20 2024	SELL Payment of exercise price or tax liability	$120,395 $11.0 p/Share	10,945 Reduced 2.39%	446,307 Common Shares
Jun 20 2024	SELL Payment of exercise price or tax liability	$118,206 $10.8 p/Share	10,945 Reduced 2.34%	457,252 Common Shares
May 20 2024	SELL Payment of exercise price or tax liability	$181,954 $11.37 p/Share	16,003 Reduced 3.31%	468,197 Common Shares
Apr 20 2024	SELL Payment of exercise price or tax liability	$167,380 $10.46 p/Share	16,002 Reduced 3.2%	484,200 Common Shares
Mar 20 2024	SELL Payment of exercise price or tax liability	$160,190 $10.01 p/Share	16,003 Reduced 3.1%	500,202 Common Shares
Feb 20 2024	SELL Payment of exercise price or tax liability	$184,663 $11.54 p/Share	16,002 Reduced 3.01%	516,205 Common Shares
Feb 09 2024	SELL Open market or private sale	$1,058,694 $10.92 p/Share	96,950 Reduced 15.41%	532,207 Common Shares
Feb 09 2024	BUY Exercise of conversion of derivative security	$373,257 $3.85 p/Share	96,950 Added 13.35%	629,157 Common Shares
Jan 20 2024	SELL Payment of exercise price or tax liability	$128,101 $10.35 p/Share	12,377 Reduced 2.27%	532,207 Common Shares

Eric Venker

President & COO

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Value

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV

Account